StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

5-Butylpyridin-3-carbonsaeure

Fusaric Acid

HCID 3442
Neue Reaktion
Drucken

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
536-69-6
Standard-SMILES
CCCCc1ccc(C(=O)O)nc1
InChIKey
DGMPVYSXXIOGJY-UHFFFAOYSA-N
Summenformel
C10H13NO2
Durchschnittliche Molmasse
179,22 g/mol
Monoisotopische Masse
179,09462866

Überblick

Fusaric acid is a member of pyridines and an aromatic carboxylic acid.

Namen und Bezeichner

Bevorzugter Name
Fusaric Acid
IUPAC
5-butylpyridine-2-carboxylic acid
Lokaler Name
5-Butylpyridin-3-carbonsaeure
Englischer Name
Fusaric acid
Summenformel
C10H13NO2
Molmasse
179.22

Namen und Synonyme

fusaric acid5-Butylpicolinic acid536-69-65-Butylpyridine-2-carboxylic acidFusarinic acid5-Butyl-2-pyridinecarboxylic acid2-Pyridinecarboxylic acid, 5-butyl-Picolinic acid, 5-butyl-5-n-Butylpyridine-2-carboxylic acidDTXSID5023085JWJ963070NNSC-19870
Weitere Namen anzeigen
FusaricNSC 135043FURASIC ACIDfusarinicacidFUSARIC ACID 99%Fusaric acid,99%Butylpicolinic acid
DTXCID703085Acid, FusaricFusarate, Calcium5-Butyl-2-pyridinedicarboxylic Acid5 Butyl 2 pyridinedicarboxylic AcidAcid, 5-Butyl-2-pyridinedicarboxylicRefChem:141890208-643-0

Datenbank-Bezeichner

CAS
536-69-6
PubChem CID
3442
DTXSID
DTXSID5023085
ChEMBL
CHEMBL24510

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP
2,6
Polarare Oberfläche (TPSA)
50,2 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
3
Frei drehbare Bindungen
4
Schwere Atome
13
Formalladung
0
Komplexität
170

Experimentelle und physikochemische Eigenschaften

DrugsPharmaceuticals -> Antibiotics
LogP0.68
Color/FormCOLORLESS CRYSTALS
Melting Point96-98 °C

Physikochemische Eigenschaften

Schmelzpunkt
96 · 96-100 °C
Siedepunkt
311.75 °C · 311.75°C (rough estimate)
Dichte
1.1248 · 1.1248 (rough estimate)
Brechungsindex
1.571 · 1.5710 (estimate)
storage temp.
-20 °C · Inert atmosphere,Store in freezer, under -20°C
Löslichkeit
50 mg/mL, · ethanol: 50 mg/mL, clear, faintly yellow
Aggregatzustand
Crystalline Powder
pka
1.11 · 1.11±0.50(Predicted)

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Warning

H302 (98.6%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 69 reports by companies from 2 notifications to the ECHA C&L Inventory.

Gefahrenhinweise

Special ReportsA REVIEW WITH 28 REFERENCES OF THE ROLE OF FUSARIC ACID AS A PLANT TOXIN.[KALYANASUNDARAM R; MODE OF ACTION OF FUSARIC ACID; PLANT DIS PROBL PROC INT SYMP 1ST: 142 (1970)]
Hazard Classes and CategoriesAcute Tox. 4 (98.6%)

Toxikologische Informationen

TreatmentNatamycin ophthalmic suspension is the drug of choice for filamentous fungal infections such as mycotic keratitis. (L1964)
Interactions · 1 Eintrag

WHEN FUSARIC ACID (100 MG/KG, IP) WAS ADMIN TO MALE MICE 6 HR AFTER ALCOHOL WITHDRAWAL, BRAIN NORADRENALINE, DOPAMINE, & SEROTONIN CONCN WERE 112.8, 186.4, & 652.8 NG/G 4 HR LATER. FUSARIC ACID ADMIN DECREASED BRAIN NORADRENALINE LEVEL ACCOMPANIED BY AN ENHANCED ALCOHOL WITHDRAWAL SYNDROME.

Health EffectsFusaric acid can contribute to mycotic keratitis infections. It also has developmental and neurological effects. (A3021, A3023)
Exposure RoutesOral, dermal, inhalation, and parenteral (contaminated drugs). (A3101)

Chemie und Industrie

Pharmakologische Informationen

Mechanism of Action · 5 Einträge

FUSARIC ACID SUPPRESSED RAPID EYE MOVEMENT (REM) SLEEP IN CATS BUT HAD NO SIGNIFICANT EFFECT ON SLOW WAVE SLEEP. REM SLEEP USUALLY REBOUNDED AFTER A PERIOD OF DRUG-INDUCED SUPPRESSION, INDICATING THAT, ALTHOUGH FUSARIC ACID SUPPRESSED THE PERIPHERAL MANIFESTATIONS OF REM, THE BIOLOGICAL NEED FOR REM WAS NOT ALTERED.

FUSARIC ACID INHIBITED NORADRENALINE & DOPAMINE UPTAKE IN SYNAPTOSOMES FROM RAT HYPOTHALAMUS & CORPUS STRIATUM. THE BASAL OVERFLOW OF NORADRENALINE & DOPAMINE FROM BRAIN STEM & CORPUS STRIATUM SLICES WAS STIMULATED BY FUSARIC ACID. THE DATA SHOW THAT FUSARIC ACID, A DOPAMINE-BETA-HYDROXYLASE INHIBITOR, ALSO EXERTS MARKED EFFECTS IN THE CNS BY INTERFERING WITH OTHER SYNAPTOSOMAL FUNCTIONS.

FUSARIC ACID (100 MG/KG, IP) INCREASED THE LEVELS OF TRYPTOPHAN, SEROTONIN, & 5-HYDROXYINDOLEACETIC ACID IN RAT BRAIN & THE LEVEL OF FREE TRYPTOPHAN IN THE BLOOD INDICATING THAT IN ADDITION TO ITS CNS EFFECT, FUSARIC ACID EXERTS A PERIPHERAL ACTION ON SEROTONIN METABOLISM BY INHIBITING TRYPTOPHAN BINDING TO SERUM ALBUMIN.

FUSARIC ACID (75 MG/KG, IP), AN INHIBITOR OF DOPAMINE BETA-HYDROXYLASE, EFFECTIVE IN THE RELIEF OF TREMORS, RIGIDITY, & SPEECH DIFFICULTIES ASSOCIATED WITH PARKINSONS DISEASE, INCREASED THE BRAIN SEROTONIN LEVELS & DECREASED THE BRAIN NORADRENALINE LEVELS OF RATS.

FUSARIC ACID (FA) INCREASED MONOSYNAPTIC REFLEX NEURAL ACTIVITY IN A DOSE-DEPENDENT MANNER IN CATS. FA DID NOT INCREASE THE BLOOD PRESSURE BUT INHIBITED THE SYNTHESIS OF NOREPINEPHRINE FROM DOPAMINE.

Metabolism/Metabolites · 4 Einträge

ZINC, COBALT, & MOLYBDENUM ENHANCE THE BIOSYNTHESIS OF FUSARIC ACID BY FUSARIUM OXYSPORUM. NICOTINIC ACID WAS SLIGHTLY STIMULATORY, & TRYPTOPHAN, CYSTEINE, & THE COMBINATION OF INDOLEACETATE & SERINE MARKEDLY STIMULATED THE SYNTHESIS.

INDOLEACETIC ACID ALONE INHIBITED FUSARIC ACID FORMATION BY FUSARIUM OXYSPORUM, BUT INDOLEACETATE WITH SERINE HAD A STIMULATORY EFFECT. THE COMBINATION OF INDOLEACETATE & SERINE WITH TRYPTOPHAN INHIBITED THE BIOSYNTHESIS. HOMOSERINE SHOWED STIMULATORY ACTIVITY INDEPENDENT OF THE OTHER COMPOUNDS TESTED SINCE IT WAS NOT AFFECTED BY THEIR PRESENCE.

THE BIOSYNTHETIC PATHWAY FOR FUSARIC ACID WAS INVESTIGATED USING 1-(13)C-LABELED & 2-(13)C-LABELED ASPARTATE. CARBON ATOMS 2, 3, 4, & 7 WERE DERIVED FROM ACETATE VIA ASPARTATE OR A RELATED C4 DICARBOXYLIC ACID, WHEREAS CARBONS 5, 6, 8, 9, 10, & 11 WERE DERIVED MORE DIRECTLY FROM ACETATE. ASPARTIC ACID APPARENTLY IS METABOLIZED TO FUSARIC ACID VIA OXALOACETATE, & L-ASPARTATE SERVES AS A DONOR OF NITROGEN, IN AN AMINOTRANSFERASE REACTION, TO A SEPARATE OXALACETATE POOL OF PRIMARILY ENDOGENOUS ORIGIN.

Zugehörige Reaktionen

25
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 325932
HRID 325932als Edukt
Reaktionsgleichung von HRID 353872
HRID 353872als Edukt
Reaktionsgleichung von HRID 448440
HRID 448440als Edukt
Reaktionsgleichung von HRID 542691
HRID 542691als Edukt
Reaktionsgleichung von HRID 696271
HRID 696271als Edukt
Reaktionsgleichung von HRID 719463
HRID 719463als Edukt
Reaktionsgleichung von HRID 724474
HRID 724474als Edukt
Reaktionsgleichung von HRID 746558
HRID 746558als Edukt
ZurückSeite 1 von 4

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
ChEBI
CHEBI:5199
UNII
JWJ963070N
EC Number
208-643-0
Nikkaji
J12.987I
Farbe
Off-white to faint yellow
Merck
14 · 14,4314
BRN
125804 · 125804
InChI
1S/C10H13NO2/c1-2-3-4-8-5-6-9(10(12)13)11-7-8/h5-7H,2-4H2,1H3,(H,12,13)
InChIKey
DGMPVYSXXIOGJY-UHFFFAOYSA-N
SMILES
CCCCc1ccc(nc1)C(O)=O
LogP
1.96 · 1.960 (est)
CAS Datenbank
536 · 536-69-6(CAS DataBase Reference)
EPA chemische Informationen
2 · 2-Pyridinecarboxylic acid, 5-butyl- (536-69-6)
Toxicity Summary · 1 Eintrag

Fusaric acid affects neurotransmitter levels by acting as a partial inhibitor on tyrosine-hydroxylase and an inhibitor on dopamine-beta-hydroxylase. This has been shown to cause elevated serotonin, 5-hydroxyindoleacetic acid, tyrosine, and dopamine levels in the brain, as well as decreased norepinephrine levels. These changes in neurotransmitter levels may be responsible for effects such as hypotension, altered behavior and locomotive activity, neurological disorders, and developmental problems. (A3020, A3021, A3022, A3023)

Signs and SymptomsFusaric acid can cause vomiting, hypotension, and alterations in behavioral and locomotive activity. (A3020, A3022, A3023)
Natural Pollution SourcesTHE TOXIN ISOLATED FROM THE CULTURE MEDIA OF FUSARIUM OXYSPORUM F VASINFECTUM WAS IDENTIFIED AS FUSARIC ACID.
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Non-Human Toxicity Excerpts · 4 Einträge

DOPAMINE BETA-HYDROXYLASE INHIBITOR & HYPOTENSIVE ACTIVITY...

IN THE MOUSE & RAT, A MAX DAILY DOSE OF 125 MG/KG ORALLY CAUSED NO DEFECTS BUT DELAY IN OSSIFICATION & GROWTH OF THE MOUSE FETUSES WAS FOUND. AT THE SAME DOSE, NO EFFECTS WERE FOUND IN THE RABBIT. /FUSARIC ACID-CA/

FUSARIC ACID (10 MG/KG, IV) CAUSED A RAPID & DOSE-RELATED HYPOTENSION, TACHYCARDIA, TACHYPNEA, INCREASE IN BLOOD FLOW IN THE UPPER MESENTERIC ARTERY, & DECREASE IN BLOOD FLOW IN THE FEMORAL ARTERY IN DOGS. FUSARIC ACID (0.3-3 MG) HAD A DOSE-DEPENDENT NEGATIVE INOTROPIC & NODAL RHYTHM DECREASING ACTIVITY IN NODAL & PAPILLARY MUSCLE PREPARATIONS.

THE EFFECTS OF FUSARIC ACID (FA), A DOPAMINE-BETA-HYDROXYLASE INHIBITOR, WERE DETERMINED ON AGGRESSION, MOTOR ACTIVITY, & BRAIN MONAMINES AT DOSES OF 3.2-60 MG/KG FOLLOWING ADMIN OF DIETARY SUPPLEMENTS OF L-TYROSINE OR BALANCED PROTEIN TO MALE ALBINO MICE. COMPARED TO SALINE-INJECTED CONTROL ANIMALS, BOTH AGGRESSION & MOTOR ACTIVITY WERE REDUCED BY THE HIGHEST DOSES OF FUSARIC ACID. TREATMENT WITH FA AT DOSES OF 30 TO 60 MG/KG DECREASED BRAIN NOREPINEPHRINE, DOPAMINE, & BRAIN TYROSINE IN ANIMALS FED THE TYROSINE SUPPLEMENT. IN CONTRAST, FA INCREASED 5-HYDROXYTRYPTAMINE & CAUSED MARKED INCREASES IN 5-HYDROXYINDOLEACETIC ACID AT THE HIGHEST DOSES.

Sicherheitsdaten

F
10
wgk
3
tsca
TSCA listed
ridadr
2811
hs_code
29333999
RTECS-Nr.
US5625000
risk_code
22
Toxizität
LD50 orally in mice: 230 mg/kg (Ishii)
hazard_code
Xn
safety_code
24/25
hazard_class
6.1(b)
packing_group
III
Speicherklasse
11 - Combustible Solids
Giftige Stoffe Daten
536-69-6(Hazardous Substances Data)
Hazard Classifications
Acute Tox. 4 Oral

IN RATS, THE MAJOR METABOLITE OF 5-(N-BUTYL)PICOLINAMIDE IS FUSARIC ACID, WHICH IS A DOPAMINE-BETA-HYDROXYLASE INHIBITOR. HENCE, ADMIN OF THE DRUG LOWERS THE CONCN OF ENDOGENOUS L-NORADRENALINE IN THE BRAIN, HEART, & SPLEEN.

MeSH Pharmacological Classification · 3 Einträge

Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.

Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons.

Compounds that inhibit cell production of DNA or RNA.

Absorption, Distribution and Excretion · 1 Eintrag

THE METABOLISM OF (14)C-LABELED FUSARIC ACID WAS STUDIED IN MALE & PREGNANT RATS AFTER ORAL ADMIN OF 20 MG/KG. THE MAJOR PART OF RADIOACTIVITY RETAINED IN THE BODY OF MALE RATS WAS IN THE KIDNEY, LIVER, & PLASMA 30 MIN AFTER ADMIN, & DECLINED RAPIDLY THEREAFTER. MOST (92.9%) OF THE DOSE APPEARED IN URINE BY 24 HR AFTER ADMIN & 93.1% BY 48 HR. A CONSIDERABLE AMOUNT OF RADIOACTIVITY APPEARED IN BILE WITHIN 1 HR AFTER ADMIN. AN EASY TRANSFER OF RADIOACTIVITY INTO THE FETUS WAS SHOWN BY RADIOAUTOGRAPHY OF PREGNANT RATS. THE ACTIVITY WAS NOT DETECTED IN THE FETUS IN 24 HR.

Verwendung und Herstellung

Uses · 2 Einträge

MEDICATION

Fusaric acid is a mycotoxin found in various Fusarium species such as Fusarium moniliforme. It has been proposed for a various therapeutic applications but is primarily used as a research tool. Fusaric acid can be found in contaminated corn and cereal grains including barley, wheat, millets and sorghum. (L1963, A3020)

Methods of Manufacturing · 3 Einträge

HARDEGGER, NIKLES, HELV CHIM ACTA 39, 505 (1956)...

LARGE QUANTITIES OF FUSARIC ACID WERE PRODUCED BY FUSARIUM SPECIES GROWN ON A MODIFIED RICHARDS MEDIUM CONTAINING 2 MOLAR, BUT NOT 0.05 MOLAR GLUCOSE.

ANTIBIOTIC (WILTING AGENT) FIRST ISOLATED FROM THE FUNGUS FUSARIUM HETEROSPORIUM, NEES: YABUTA ET AL, J AGR CHEM SOC JAPAN 10, 1059 (1934). ISOLATION FROM OTHER FUSARIUM SPECIES & FROM GIBBERELLA FUJIKUROI & SYNTHESIS: PLATTNER ET AL, HELV CHIM ACTA 37, 1379 (1954).

General Manufacturing Information · 2 Einträge

2-Pyridinecarboxylic acid, 5-butyl-: INACTIVE

ADDITION OF EXCESSIVE AMOUNTS OF ZINC (30 MG/L) TO THE MEDIUM OF VIRULENT STRAIN OF FUSARIUM OXYSPORUM VASINFECTUM DECREASED THE CONTENT OF FUSARIC ACID BY 40% IN COMPARISON TO THAT IN THE SAME STRAIN GROWN ON MEDIUM WITH A NORMAL AMOUNT OF ZINC (0.2 MG/L). EXCESSIVE ZINC APPARENTLY ALTERS THE METABOLIC PATHWAY ASSOCIATED WITH FUSARIC ACID FORMATION & LEADS TO ACTIVATION OF THE DEHYDROGENASE SYSTEM. THE MAIN EFFECT OF EXCESSIVE ZINC APPEARS NOT TO BE LOSS OF VIABILITY BY PATHOGENIC FORMS, BUT LOSS OF VIRULENCE.

Anwendungen · 1 Eintrag

VerwendenFusaric acid may be used as a derivatizing reagent for the quantification of hydroxysteroids and dehydroepiandrosterone (DHEA)and sulfated DHEA in biological samples using liquid chromatography electrospray-ionization-tandem mass spectrometry (LC/ESI-MS/MS) technique.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

N,N-DimethylhydrazinAcetonitrilEthanolKaliumhydroxid2-ChloracrylonitrilNatriumchloridFormaldehydN,N-DiethylethanaminTrichlormethanSodium phosphate tribasic dodecahydrateDimethylammoniumchlorid1,4-DioxanDiethyletherHydrogenchloridDichlormethanMagnesiumsulfatSchwefelsureNatriumcarbonatHexanal

Ergänzende Hinweise

DefinitionA mycotoxin and picolinic acid, that is an antibiotic and wilting agent that causes yellowing of infected plants.